Combo Therapy May Improve HbA1c in Type 2 Diabetes - Top-Institutions - MDSpire

Combo Therapy May Improve HbA1c in Type 2 Diabetes

Oral orforglipron could be more effective in reducing hemoglobin A1c and body weight, with no increased risk of hypoglycemia in patients with inadequately controlled type 2 diabetes.

  • By

  • Andrea Surnit

  • June 12, 2026

  • 4 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of Bari Aldo Moro
    University of Bari Aldo Moro

    Bari, Italy

    Key Differentiators

    • Endocrinology

  • #2

    University Hospitals of Cleveland
    University Hospitals of Cleveland

    Cleveland, Ohio

    Key Differentiators

    • Endocrinology

  • #3

    Dokkyo Medical University Nikko Medical Center
    Dokkyo Medical University Nikko Medical Center

    Nikko, Japan

    Key Differentiators

    • Endocrinology

  • #4

    Shanghai Institute of Endocrine and Metabolic Diseases
    Shanghai Institute of Endocrine and Metabolic Diseases

    Shanghai, China

    Key Differentiators

    • Endocrinology

  • #5

    Ruijin Hospital
    Ruijin Hospital

    Shanghai, China

    Key Differentiators

    • Endocrinology

Original Source(s)

Combo Therapy May Improve HbA1c in Type 2 Diabetes

  • by Andrea Surnit

  • June 12, 2026

Related Content

High prevalence of thyroid nodules and their association with cardiometabolic risk in Mongolia

Semaglutide Tied to Aging Clocks in HIV

A posthoc analysis of a phase 2b trial found favorable changes in DNA methylation–based aging biomarkers among patients with human immunodeficiency virus–associated lipohypertrophy.

Male puberty is understudied — but when it starts may predict long-term health risks